NMDA Receptor Modulation for the Treatment of Bipolar I Disorder

Condition:   Bipolar I Disorder Interventions:   Drug: NMDAE;   Drug: Placebo Cap Sponsors:   China Medical University Hospital;   National Science and Technology Council Not yet recruiting

Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials